News and Presentations
NEWS
July 9, 2025
Appointment highlights DIMERx’s next phase of growth as it advances non-addictive pain therapeutics with support from the NIH HEAL Initiative
June 25, 2025
The Award Highlights the Promise of Exclusively Targeting Peripheral Opioid Receptors to Treat Chronic Pain Without the Risk of Addiction and Dependence
May 22, 2024
Company to Pursue Applications in Rare Diseases and Proprietary Medical Food Domains
Deal Unlocks Opportunities for Future Collaborations
October 4, 2023
Presentation will discuss the potential of DMX-101 as a Phase 2-ready non-addictive opioid for chronic pain
September 19, 2023
August 15, 2023
Potential to treat chronic pain without risks associated with traditional opioids by exclusively targeting peripheral pain receptors
PRESENTATIONS AND PUBLICATIONS
July 2025
Non-Confidential Corporate Presentation
September 6, 2023
